Loading provider…
Loading provider…
Nuclear Medicine Physician in Houston, TX
NPI: 1649447525Primary Employer
Physicians Referral Service
mdanderson.org
HQ Phone
Get M.D. Gregory's Phone NumberMobile
Get M.D. Gregory's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
TX State Medical License
FL State Medical License
2025 - 2027
NY State Medical License
2006 - 2027
TX State Medical License
2011 - 2025

American Board of Nuclear Medicine
Nuclear Medicine

American Board of Radiology
Diagnostic Radiology
Emory School of Medicine
med.emory.edu
Residency • Nuclear Medicine
2002 - 2004
SUNY Upstate Medical University
upstate.edu
Residency • Radiology-Diagnostic
2008 - 2011
Memorial Sloan Kettering Cancer Center
Fellowship • Nuclear Oncology
2004 - 2006
Fluminense Federal University Faculty of Medicine
Medical School
Until 1998
National Cancer Institute
Post-Doctoral Fellowship • Molecular Imaging
—
ECU Health Medical Center/East Carolina University
Internship • Internal Medicine
—
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 78815Nuclear medicine study with CT imaging skull base to mid-thigh | 436 | 448 |
| 2 | 77080Bone density measurement using dedicated X-ray machine | 330 | 330 |
| 3 | 78306Bone and/or joint imaging, whole body | 145 | 148 |
| 4 | 78816Nuclear medicine study with CT imaging whole body | 143 | 148 |
| 5 | 77081Dxa bone density measurement of forearm, finger, hand, or foot | 76 | 76 |
Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCIST.
Authors: Vivek Subbiah, Homer Macapinlac, Eric Rohren
Publication Date: 2018-08-26
Prostate-Specific Membrane Antigen-Targeted Radiopharmaceuticals in Diagnosis and Therapy of Prostate Cancer: Current Status and Future Perspectives.
Authors: Mai Lin, Robert Ta, Kalevi Kairemo, Dao Le, Gregory Ravizzini
Publication Date: 2020-06-27
Lead Sponsor: M.D. Anderson Cancer Center
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Positron Emission Tomography, PROCEDURE: Computed Tomography, DRUG: Gallium Ga 68-labeled PSMA-11
Lead Sponsor: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Positron Emission Tomography, PROCEDURE: Computed Tomography, DRUG: Fluciclovine F18